As shown, the protein level of TGFβ in AAA tissues was significantly increased in both the FAM3A overexpression group and recombinant FAM3A supplementation group compared to their matched control groups (Fig. 8a). The gene discussed is FAM3A; the disease is triple-A syndrome.